United States· US:82718-1110_de4b93cc-1f65-1a4a-e053-2995a90a48a5
Blockaid
A medicinal product containing tetracaine; lidocaine, registered in United States by SofTap Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TETRACAINE; LIDOCAINE
- Manufacturer
- SofTap Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11827181110110 g in 1 TUBE (82718-1110-1)
- ndc1182718-1110-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tetracaine; lidocaine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPLIAGLISEgis Pharmaceuticals PLC, Budapešť
- United KingdomPliaglis 70mg/g / 70mg/g creamCroma-Pharma GmbH
- GermanyPliaglisCroma Pharma Gmbh
- NetherlandsPliaglis 70 mg/g + 70 mg/g crèmeCroma Pharma GmbH
- PolandPliaglisEgis Pharmaceuticals PLC
- SwedenRapydan 70 mg/70 mg Medicinskt plåsterEurocept International B.V.
- CanadaPLIAGLISSCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
- SpainPLIAGLIS 70 MG/G + 70 MG/G CREMAIndustrial Farmaceutica Cantabria S.A.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Pliaglis, Rapydan
- Belgium · Pliaglis, Rapydan
- Bulgaria · Плиаглис
- Czechia · Pliaglis
- Germany · Pliaglis, Rapydan
- Denmark · Pliapel, Ralydan
- Spain · Pliaglis
- United Kingdom (Northern Ireland) · Pliaglis, Rapydan
- Greece · Pliaglis
- Hungary · Pliapeel
- Ireland · Pliaglis
- Italy · Pliaglis
- Lithuania · Cessolute
- Luxembourg · Pliaglis, Rapydan
- Latvia · Cessolute
- Netherlands · Pliaglis, Rapydan
- Norway · Pliapel, Rapydan
- Poland · Pliaglis
- Portugal · Pliaglis
- Sweden · Rapydan
- Slovakia · Pliaglis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c208271b-3f8a-4255-83e2-565bf4183f77 GET /v1/drugs/c208271b-3f8a-4255-83e2-565bf4183f77?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".02; .03",
"substance": "TETRACAINE; LIDOCAINE",
"productndc": "82718-1110",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/10g; g/10g",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about tetracaine; lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.